acetaminophen pm
- Product NDC
- 41163-515
- 11-digit product format
- 411630515
- Labeler code
- 41163
- Product ID
- 41163-515_24b11c3b-9c19-ff00-e063-6394a90adbed
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen and Diphenhydramine Hydrochloride
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- United Natural Foods, Inc. dba UNFI
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-09-01
- Substance
- ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
- Active strength
- 500; 25 mg/1; mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 41163-515 | 41163-515-02 | D | Discontinued by firm | 2026-10-12 | |
| excluded package | package | 41163-515 | 41163-515-14 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 41163-515-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 41163-515-14 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 41163-515-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 41163-515-14 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 41163-515-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 41163-515-14 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 41163-515-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 41163-515-14 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 41163-515-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 41163-515-14 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 41163-515-02 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 41163-515-14 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 41163-515-02 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 41163-515-14 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 41163-515-02 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 41163-515-14 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 41163-515-02 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 41163-515-14 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 41163-515-02 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 41163-515-14 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 41163-515-14 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 41163-515-02 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 41163-515-14 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 41163-515-02 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- acetaminophen pm
- Brand name suffix
- extra strength
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
| DIPHENHYDRAMINE HYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| TC2D6JAD40 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1092189 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f86a11af-6d3c-4638-870d-a663ddf49371 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41163-515-01 | acetaminophen pmextra strength | 1 in 1 CARTON | TABLET, COATED | 1 | 10 | |
| 41163-515-01 | acetaminophen pmextra strength | 24 in 1 BOTTLE, PLASTIC | TABLET, COATED | 24 | 10 | |
| 41163-515-02 | acetaminophen pmextra strength | 50 in 1 BOTTLE, PLASTIC | TABLET, COATED | 50 | 10 | |
| 41163-515-02 | acetaminophen pmextra strength | 1 in 1 CARTON | TABLET, COATED | 1 | 10 | |
| 41163-515-03 | acetaminophen pmextra strength | 100 in 1 BOTTLE, PLASTIC | TABLET, COATED | 100 | 10 | |
| 41163-515-03 | acetaminophen pmextra strength | 1 in 1 CARTON | TABLET, COATED | 1 | 10 | |
| 41163-515-14 | acetaminophen pmextra strength | 200 in 1 BOTTLE, PLASTIC | TABLET, COATED | 200 | 10 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 41163-515-01 | EA - Each | 41163-515 | 5c6c8447-ffdb-4a36-ad82-f857e36fb2a5 | 1 | 2016-10-06 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 41163-515 | ACETAMINOPHEN PM EXTRA STRENGTH (ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE) TABLET, COATED [UNITED NATURAL FOODS, INC. DBA UNFI] | 10 | Current NDC, Legacy NDC, 7 package rows | 20241019_f86a11af-6d3c-4638-870d-a663ddf49371.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | A-S Medication Solutions | 92559d65-f5e2-4054-9763-b9c560452dab | 2026-05-22 | Warnings | M013 |
| Acetaminophen PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Grocery Outlet, Inc. | 441d2629-3fff-0bf1-e063-6394a90aa9b6 | 2026-05-21 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Grocery Outlet, Inc. | 441d1bde-d677-fab7-e063-6394a90aaad4 | 2026-05-21 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Grocery Outlet, Inc. | 441d3a39-cc55-3c7c-e063-6394a90ad7a7 | 2026-05-21 | Warnings | M013 |
| INFANTS Pain and Fever | ACETAMINOPHEN | Aurohealth LLC | b3f57af5-661f-4534-9eed-76e431f338db | 2026-05-20 | Warnings | M013 |
| Good Sense aspirin | ASPIRIN | L. Perrigo Company | e150dd59-8db8-449f-9c9a-1aa6deb3be2e | 2026-05-20 | Warnings | M013 |
| Infants Pain and Fever | ACETAMINOPHEN | Aurohealth LLC | e837538d-0515-4f99-b04c-fda63b28777e | 2026-05-20 | Warnings | M013 |
| Walgreens Headache Relief Extra Strength | ACETAMINOPHEN 250MG, ASPIRIN 250MG AND CAFFEINE 65MG | Walgreens | 52109b65-3bf1-de38-e063-6394a90a9727 | 2026-05-18 | Warnings | M013 |
| Genexa Infants Pain and Fever | ACETAMINOPHEN | Genexa Inc. | 5220a40d-4a4f-5bad-e063-6394a90a93b0 | 2026-05-18 | Warnings | M013 |
| childrens Pain and Fever | ACETAMINOPHEN | Topco Associates, LLC | 7f7b4377-9b40-4a12-808b-f1cd7d241b0d | 2026-05-18 | Warnings | M013 |
| Aspirin Enteric Coated, Regular Strength | ASPIRIN | Gendose Pharmaceuticals, LLC | 10b9a1fc-70d1-44ea-a6de-5c1943e8fbaa | 2026-05-15 | Warnings | M013 |
| Aspirin | ASPIRIN | Gendose Pharmaceuticals, LLC | 119de26f-cce5-401c-81fa-775ebebf6c6f | 2026-05-15 | Warnings | M013 |
| Aspirin Low Dose Chewable Orange | ASPIRIN | Cardinal Health 107, LLC | 827bbe77-febb-4352-892f-3fbb2acfc7d5 | 2026-05-14 | Warnings | M013 |
| Aspirin | ASPIRIN | Topco Associates, LLC | 56c125de-fabf-41fa-88a4-760d2793f202 | 2026-05-13 | Warnings | M013 |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Chain Drug Marketing Association, Inc. | 17216bf3-bed0-4d7a-994e-76a0e4c79c5c | 2026-05-13 | Warnings | M013 |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | A-S Medication Solutions | c445c6bb-69a8-492e-b100-ce942707f203 | 2026-05-12 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | Valu Merchandisers Company | 1754a9f2-e7e5-4efb-a728-6ba2a7155d11 | 2026-05-12 | Warnings | M013 |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | Target Corporation | bc65e205-64fd-4764-8c5e-2793af4e9adf | 2026-05-12 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | DOLGENCORP, LLC | a7e27000-a26b-46c2-823e-663f4e76db74 | 2026-05-11 | Warnings | M013 |
| Market Basket Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Demoulas Super Markets, Inc. | e15439c7-0e3c-7752-e053-2995a90a1a40 | 2026-05-11 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1092189 | acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG Oral Tablet | PSN | f86a11af-6d3c-4638-870d-a663ddf49371 | 10 |
| 1092189 | acetaminophen 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet | SCD | f86a11af-6d3c-4638-870d-a663ddf49371 | 10 |
| 1092189 | APAP 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet | SY | f86a11af-6d3c-4638-870d-a663ddf49371 | 10 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 41163-515-01 | 41163051501 | 1 BOTTLE, PLASTIC in 1 CARTON (41163-515-01) / 24 TABLET, COATED in 1 BOTTLE, PLASTIC | 2014-09-01 | 0000-00-00 | No | No | Current |
| 41163-515-02 | 41163051502 | 50 in 1 BOTTLE, PLASTIC | Historical | ||||
| 41163-515-03 | 41163051503 | 1 BOTTLE, PLASTIC in 1 CARTON (41163-515-03) / 100 TABLET, COATED in 1 BOTTLE, PLASTIC | 2014-09-01 | 0000-00-00 | No | No | Current |
| 41163-515-14 | 41163051514 | 200 in 1 BOTTLE, PLASTIC | Historical |